Tendel Therapies Inc.
Kensington, CA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 420 Yale Ave, Kensington, CA 94708, USA
- Website
- tendel.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $599,980 |
Contract awards
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of California, Davis | P01AI181044 | $485,352 | |
| University Of California, Davis | P01AI178375 | $223,080 |
Similar vendors
About the company
Tendel Therapies Inc. is a biotechnology company focused on developing innovative vaccine technologies and advanced immunological approaches for challenging medical conditions. Registered in SAM.gov since February 28, 2019, the company specializes in developing memory-promoting vaccines and genetic adjuvant technologies targeting complex infectious diseases such as HIV, SARS-CoV-2, and influenza. As a for-profit corporate entity, Tendel Therapies operates in the biotechnology research and development sector, with a particular emphasis on creating advanced vaccine platforms that generate durable and robust immune responses.
In terms of federal contract awards, Tendel Therapies has been awarded a significant contract from the National Institute of Allergy and Infectious Diseases (NIAID) under the Small Business Innovation Research (SBIR) program. Specifically, the company received a $599,980 firm fixed price contract focused on developing research and development services related to genetic adjuvants that promote durable anti-influenza stem antibodies in older adults. The contract was set aside for small businesses and is structured as a definitive contract with an ultimate completion date of September 29, 2025, demonstrating the company's capability to secure competitive federal contract opportunities in the biomedical research domain.
Regarding federal grant awards, Tendel Therapies has secured multiple substantial grants from NIAID and the National Institute of Mental Health, primarily targeting advanced vaccine and immunological research. These grants include a $999,991 project grant for developing an HIV reservoir-depletion agent using a bispecific antibody (BSAB-98), a grant for producing a SARS-CoV-2 booster vaccine targeting T follicular helper cells, a grant exploring genetic adjuvants to elicit neutralizing antibodies against HIV, and a project investigating CCR5 immunotoxins as potential HIV cure components. The grants range from $600,000 to $1 million and focus on innovative approaches to vaccine development, immune response enhancement, and potential therapeutic strategies for complex infectious diseases, particularly HIV and SARS-CoV-2.
Quick answers
Is Tendel Therapies Inc. registered in SAM.gov?
Yes. Tendel Therapies Inc.'s SAM.gov registration is active through May 25, 2027.
What is Tendel Therapies Inc.'s CAGE code?
Tendel Therapies Inc.'s CAGE code is 89CR8, and its Unique Entity ID (UEI) is JA9BDUH73852.
How much has Tendel Therapies Inc. received in federal contracts?
Federal contracts obligated $599,980 to Tendel Therapies Inc. in fiscal years 2023 through 2027.
What is Tendel Therapies Inc.'s most recent federal award?
Tendel Therapies Inc.'s most recent federal grant award is Optimizing SIV reservoir depletion by tendel BSAB-98 - we are developing an HIV reservoir-depletion agent that… (R44AI192249), from National Institute of Allergy and Infectious Diseases (NIH), on August 13, 2025.
On GovTribe
See Tendel Therapies Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors